PHARMACEUTICAL FORMULATIONS INC

Pharmaceutical Formulations Inc. has long anchored its position in SIC 2834’s Pharmaceutical Preparations space by producing sterile injectables, oral suspensions, and bespoke compounding services that nourish hospital systems, specialty pharmacies, and select government procurement channels with finished-dose medicines and active pharmaceutical ingredients. The company emphasizes tight control over formulation development, analytical release, and packaging for chronic and acute-care therapies, leveraging partnerships with logistics specialists to feed regional inventory needs while keeping quality programs aligned with evolving FDA, DEA, and state board oversight. Its clients prize the firm’s ability to keep low-volume, high-compliance lots moving through the same production suites that handle larger-scale batches, a balancing act that also introduces material risks such as regulatory inspection outcomes, supply chain bottlenecks for critical excipients, and the capital intensity of sustained cGMP certifications. Investors watch its reporting cadence closely even as the most recent SEC disclosure remains the Form 8-K filed Dec 1999; CIK 353827 anchors public transparency. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025